- Lannett Company (NYSE:LCI) has commenced marketing Methylphenidate Hydrochloride Extended Release (ER) tablets USP (CII) in 18 mg, 27, 36 and 54 mg strengths, an AB-rated generic equivalent to the brand Concerta.
- Total U.S. sales of Methylphenidate Hydrochloride ER tablets were ~$1.4B for year ended February 2019, according to IQVIA.
- Shares are down 2% premarket.